{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:14:22Z","timestamp":1790007262005,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T00:00:00Z","timestamp":1299801600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Duchenne and Becker Muscular dystrophies (DMD\/BMD) are allelic disorders caused by mutations in the dystrophin gene, which encodes a sarcolemmal protein responsible for muscle integrity. Deletions and duplications account for approximately 75% of mutations in DMD and 85% in BMD. The implementation of techniques allowing complete gene sequencing has focused attention on small point mutations and other mechanisms underlying complex rearrangements.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We selected 47 patients (41 families; 35 DMD, 6 BMD) without deletions and duplications in <jats:italic>DMD<\/jats:italic> gene (excluded by multiplex ligation-dependent probe amplification and multiplex polymerase chain reaction analysis). This cohort was investigated by systematic direct sequence analysis to study sequence variation. We focused our attention on rare mutational events which were further studied through transcript analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We identified 40 different nucleotide alterations in DMD gene and their clinical correlates; altogether, 16 mutations were novel. DMD probands carried 9 microinsertions\/microdeletions, 19 nonsense mutations, and 7 splice-site mutations. BMD patients carried 2 nonsense mutations, 2 splice-site mutations, 1 missense substitution, and 1 single base insertion. The most frequent stop codon was TGA (n = 10 patients), followed by TAG (n = 7) and TAA (n = 4). We also analyzed the molecular mechanisms of five rare mutational events. They are two frame-shifting mutations in the <jats:italic>DMD<\/jats:italic> gene 3'end in BMD and three novel splicing defects: IVS42: c.6118-3C&gt;A, which causes a leaky splice-site; c.9560A&gt;G, which determines a cryptic splice-site activation and c.9564-426 T&gt;G, which creates pseudoexon retention within IVS65.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The analysis of our patients' sample, carrying point mutations or complex rearrangements in <jats:italic>DMD<\/jats:italic> gene, contributes to the knowledge on phenotypic correlations in dystrophinopatic patients and can provide a better understanding of pre-mRNA maturation defects and dystrophin functional domains. These data can have a prognostic relevance and can be useful in directing new therapeutic approaches, which rely on a precise definition of the genetic defects as well as their molecular consequences.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2350-12-37","type":"journal-article","created":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T19:16:40Z","timestamp":1300216600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the Dystrophin gene detected by direct sequencing"],"prefix":"10.1186","volume":"12","author":[{"given":"Francesca","family":"Magri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Del Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Govoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Gandossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Sciacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Ciscato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreina","family":"Bordoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fortunato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Lucchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Cereda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Moggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nereo","family":"Bresolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo P","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,11]]},"reference":[{"key":"771_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/jmg.25.1.9","volume":"25","author":"KE Davies","year":"1988","unstructured":"Davies KE, Smith TJ, Bundey S, et al: Mild and severe muscular dystrophy associated with deletions in Xp21 of the human \u00d7 chromosome. J Med Genet. 1988, 25: 9-13. 10.1136\/jmg.25.1.9.","journal-title":"J Med Genet"},{"key":"771_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","volume":"1","author":"AE Emery","year":"1991","unstructured":"Emery AE: Population frequencies of inherited neuromuscular diseases--a world survey. Neuromuscul Disord. 1991, 1: 19-29. 10.1016\/0960-8966(91)90039-U.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"771_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0960-8966(94)90065-5","volume":"4","author":"AE Emery","year":"1994","unstructured":"Emery AE: Some unanswered questions in Duchenne muscular dystrophy. Neuromuscul Disord. 1994, 4 (4): 301-3. 10.1016\/0960-8966(94)90065-5.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"771_CR4","first-page":"54","volume":"49","author":"AH Beggs","year":"1991","unstructured":"Beggs AH, Hoffman EP, Snyder JR, et al: Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet. 1991, 49 (1): 54-67.","journal-title":"Am J Hum Genet"},{"key":"771_CR5","first-page":"53","volume-title":"Methods in molecular medicine","author":"Curtis","year":"2001","unstructured":"Curtis , Haggerty : Deletion and duplication analysis in males affected with Duchenne or Becker muscular dystrophy. Methods in molecular medicine. Edited by: Anderson LVB. 2001, Totowa NJ: Humana Press, 43: 53-84."},{"issue":"4","key":"771_CR6","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1086\/374176","volume":"72","author":"KM Flanigan","year":"2003","unstructured":"Flanigan KM, von Niederhausern A, Dunn DM, et al: Rapid direct sequence analysis of the dystrophin gene. Am J Hum Genet. 2003, 72 (4): 931-9. 10.1086\/374176.","journal-title":"Am J Hum Genet"},{"key":"771_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.nmd.2009.08.011","volume":"11","author":"J Sedl\u00e1ckov\u00e1","year":"2009","unstructured":"Sedl\u00e1ckov\u00e1 J, Vondr\u00e1cek P, Hermanov\u00e1 M, et al: Point mutations in Czech DMD\/BMD patients and their phenotypic outcome. Neuromuscul Disord. 2009, 11: 749-53.","journal-title":"Neuromuscul Disord"},{"key":"771_CR8","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/humu.20976","volume":"30","author":"S Tuffery-Giraud","year":"2009","unstructured":"Tuffery-Giraud S, B\u00e9roud C, Leturcq F, et al: Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum Mutat. 2009, 30: 934-45. 10.1002\/humu.20976.","journal-title":"Hum Mutat"},{"key":"771_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/humu.1380040102","volume":"4","author":"RG Roberts","year":"1994","unstructured":"Roberts RG, Gardner RJ, Bobrow M: Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations. Hum Mutat. 1994, 4: 1-11. 10.1002\/humu.1380040102.","journal-title":"Hum Mutat"},{"key":"771_CR10","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/humu.21114","volume":"30","author":"KM Flanigan","year":"2009","unstructured":"Flanigan KM, Dunn DM, von Niederhausern A, et al: Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum Mutat. 2009, 30: 1657-66. 10.1002\/humu.21114.","journal-title":"Hum Mutat"},{"issue":"3","key":"771_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/humu.21426","volume":"32","author":"KM Flanigan","year":"2011","unstructured":"Flanigan KM, Dunn DM, von Niederhausern A, et al: Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene. Hum Mutat. 2011, 32 (3): 299-308. 10.1002\/humu.21426.","journal-title":"Hum Mutat"},{"issue":"3","key":"771_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/humu.18","volume":"17","author":"M Sironi","year":"2001","unstructured":"Sironi M, Corti S, Locatelli F, Cagliani R, Comi GP: A novel splice site mutation (3157+1G>T) in the dystrophin gene causing total exon skipping and DMD phenotype. Hum Mutat. 2001, 17 (3): 239-10.1002\/humu.18. Erratum in: Hum Mutat 2001, 18(6): 552","journal-title":"Hum Mutat"},{"key":"771_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ana.21290","volume":"63","author":"OL Gurvich","year":"2008","unstructured":"Gurvich OL, Tuohy TM, Howard MT, et al: DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy. Ann Neurol. 2008, 63: 81-9. 10.1002\/ana.21290.","journal-title":"Ann Neurol"},{"key":"771_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0960-8966(03)00169-X","volume":"14","author":"C B\u00e9roud","year":"2004","unstructured":"B\u00e9roud C, Carri\u00e9 A, Beldjord C, et al: Dystrophinopathy caused by mid-intronic substitutions activating cryptic exons in the DMD gene. Neuromuscul Disord. 2004, 14: 10-8.","journal-title":"Neuromuscul Disord"},{"key":"771_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/(SICI)1098-1004(199911)14:5<359::AID-HUMU1>3.0.CO;2-K","volume":"14","author":"S Tuffery-Giraud","year":"1999","unstructured":"Tuffery-Giraud S, Chambert S, Demaille J, Claustres M: Point mutations in the dystrophin gene: evidence for frequent use of cryptic splice sites as a result of splicing defects. Hum Mutat. 1999, 14: 359-68. 10.1002\/(SICI)1098-1004(199911)14:5<359::AID-HUMU1>3.0.CO;2-K.","journal-title":"Hum Mutat"},{"key":"771_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10038-005-0272-6","volume":"50","author":"VK Tran","year":"2005","unstructured":"Tran VK, Zhang Z, Yagi M, Nishiyama A, Habara Y, Takeshima Y, Matsuo M: A novel cryptic exon identified in the 3' region of intron 2 of the human dystrophin gene. J Hum Genet. 2005, 50: 425-33. 10.1007\/s10038-005-0272-6.","journal-title":"J Hum Genet"},{"key":"771_CR17","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/humu.10214","volume":"21","author":"S Tuffery-Giraud","year":"2003","unstructured":"Tuffery-Giraud S, Saquet C, Chambert S, Claustres M: Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy. Hum Mutat. 2003, 21: 608-14. 10.1002\/humu.10214.","journal-title":"Hum Mutat"},{"key":"771_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature05756","volume":"447","author":"EM Welch","year":"2007","unstructured":"Welch EM, Barton ER, Zhuo J, et al: PTC124 targets genetic disorders caused by nonsense mutations. Nature. 2007, 447: 87-91. 10.1038\/nature05756.","journal-title":"Nature"},{"issue":"11","key":"771_CR19","first-page":"783","volume":"9","author":"SA Hamed","year":"2006","unstructured":"Hamed SA: Drug evaluation: PTC-124--a potential treatment of cystic fibrosis and Duchenne muscular dystrophy. IDrugs. 2006, 9 (11): 783-9.","journal-title":"IDrugs"},{"key":"771_CR20","first-page":"950","volume":"50","author":"CJ Klein","year":"1992","unstructured":"Klein CJ, Coovert DD, Bulman DE, Ray PN, Mendell JR, Burghes AH, et al: Somatic reversion\/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet. 1992, 50: 950-9.","journal-title":"Am J Hum Genet"},{"issue":"1-3","key":"771_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0022-510X(89)90224-4","volume":"94","author":"LV Nicholson","year":"1989","unstructured":"Nicholson LV, Davison K, Johnson MA, et al: Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci. 1989, 94 (1-3): 137-146. 10.1016\/0022-510X(89)90224-4.","journal-title":"J Neurol Sci"},{"key":"771_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s004010050926","volume":"96","author":"A Prelle","year":"1998","unstructured":"Prelle A, Comi GP, Tancredi L, et al: Sarcoglycan deficiency in a large Italian population of myopathic patients. Acta Neuropathol. 1998, 96: 509-514. 10.1007\/s004010050926.","journal-title":"Acta Neuropathol"},{"key":"771_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng0498-365","volume":"18","author":"C Minetti","year":"1998","unstructured":"Minetti C, Sotgia F, Bruno C, et al: Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet. 1998, 18: 365-368. 10.1038\/ng0498-365.","journal-title":"Nat Genet"},{"key":"771_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0014-5793(97)01108-3","volume":"415","author":"G Valle","year":"1997","unstructured":"Valle G, Faulkner G, De Antoni A, et al: Telethonin, a novel sarcomeric protein of heart and skeletal muscle. FEBS Lett. 1997, 415: 163-168. 10.1016\/S0014-5793(97)01108-3.","journal-title":"FEBS Lett"},{"issue":"12","key":"771_CR25","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1093\/nar\/gnf056","volume":"30","author":"JP Schouten","year":"2002","unstructured":"Schouten JP, McElgunn CJ, Waaijer R, et al: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002, 30 (12): e57-10.1093\/nar\/gnf056.","journal-title":"Nucleic Acids Res"},{"key":"771_CR26","first-page":"298","volume":"49","author":"RG Roberts","year":"1991","unstructured":"Roberts RG, Barby TF, Manners E, Bobrow M, Bentley DR: Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet. 1991, 49: 298-310.","journal-title":"Am J Hum Genet"},{"key":"771_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N","volume":"15","author":"JT Den Dunnen","year":"2000","unstructured":"Den Dunnen JT, Antonarakis SE: Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 2000, 15: 7-12. 10.1002\/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N. Erratum in: Hum Mutat 2002, 20: 403","journal-title":"Hum Mutat"},{"key":"771_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/1066527041410418","volume":"11","author":"G Yeo","year":"2004","unstructured":"Yeo G, Burge CB: Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol. 2004, 11: 377-94. 10.1089\/1066527041410418.","journal-title":"J Comput Biol"},{"key":"771_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/humu.10295","volume":"23","author":"L Eng","year":"2004","unstructured":"Eng L, Coutinho G, Nahas S, et al: Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths. Hum Mutat. 2004, 23: 67-76. 10.1002\/humu.10295.","journal-title":"Hum Mutat"},{"issue":"11","key":"771_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.nmd.2009.08.010","volume":"19","author":"KM Flanigan","year":"2009","unstructured":"Flanigan KM, Dunn DM, von Niederhausern A, et al: DMD Trp3X nonsense mutation associated with a founder effect in North American families with mild Becker muscular dystrophy. Neuromuscul Disord. 2009, 19 (11): 743-8. 10.1016\/j.nmd.2009.08.010.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"771_CR31","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/humu.20913","volume":"30","author":"OL Gurvich","year":"2009","unstructured":"Gurvich OL, Maiti B, Weiss RB, Aggarwal G, Howard MT, Flanigan KM: DMD exon 1 truncating point mutations: amelioration of phenotype by alternative translation initiation in exon 6. Hum Mutat. 2009, 30 (4): 633-40. 10.1002\/humu.20913.","journal-title":"Hum Mutat"},{"issue":"4","key":"771_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s004390100598","volume":"109","author":"TP Kerr","year":"2001","unstructured":"Kerr TP, Sewry CA, Robb SA, Roberts RG: Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay?. Hum Genet. 2001, 109 (4): 402-7. 10.1007\/s004390100598.","journal-title":"Hum Genet"},{"key":"771_CR33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/humu.20422","volume":"28","author":"N Deburgrave","year":"2007","unstructured":"Deburgrave N, Daoud F, Llense S, et al: Protein- and mRNA-based phenotype-genotype correlations in DMD\/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene. Hum Mutat. 2007, 28: 183-95. 10.1002\/humu.20422.","journal-title":"Hum Mutat"},{"issue":"20","key":"771_CR34","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1093\/hmg\/ddp320","volume":"18","author":"F Daoud","year":"2009","unstructured":"Daoud F, Angeard N, Demerre B, et al: Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression. Hum Mol Genet. 2009, 18 (20): 3779-94. 10.1093\/hmg\/ddp320.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"771_CR35","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1002\/humu.21092","volume":"30","author":"P Spitali","year":"2009","unstructured":"Spitali P, Rimessi P, Fabris M, et al: Exon skipping-mediated dystrophin reading frame restoration for small mutations. Hum Mutat. 2009, 30 (11): 1527-34. 10.1002\/humu.21092.","journal-title":"Hum Mutat"},{"issue":"11","key":"771_CR36","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/hmg\/4.11.2171","volume":"4","author":"GP Comi","year":"1995","unstructured":"Comi GP, Ciafaloni E, de Silva HA, et al: A G+1-->A transversion at the 5' splice site of intron 69 of the dystrophin gene causing the absence of peripheral nerve Dp116 and severe clinical involvement in a DMD patient. Hum Mol Genet. 1995, 4 (11): 2171-4. 10.1093\/hmg\/4.11.2171. Erratum in: Hum Mol Genet 1996, 5(4): 562","journal-title":"Hum Mol Genet"},{"issue":"2","key":"771_CR37","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/(SICI)1098-1004(1997)9:2<188::AID-HUMU15>3.0.CO;2-Z","volume":"9","author":"FA Saad","year":"1997","unstructured":"Saad FA, Mostacciuolo ML, Trevisan CP, et al: Novel mutations and polymorphisms in the human dystrophin gene detected by double-strand conformation analysis. Hum Mutat. 1997, 9 (2): 188-90. 10.1002\/(SICI)1098-1004(1997)9:2<188::AID-HUMU15>3.0.CO;2-Z.","journal-title":"Hum Mutat"},{"issue":"4","key":"771_CR38","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1212\/WNL.57.4.645","volume":"57","author":"JR Mendell","year":"2001","unstructured":"Mendell JR, Buzin CH, Feng J, et al: Diagnosis of Duchenne dystrophy by enhanced detection of small mutations. Neurology. 2001, 57 (4): 645-50.","journal-title":"Neurology"},{"issue":"6","key":"771_CR39","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jmg.2006.047464","volume":"44","author":"PJ Taylor","year":"2007","unstructured":"Taylor PJ, Maroulis S, Mullan GL, et al: Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy. J Med Genet. 2007, 44 (6): 368-72. 10.1136\/jmg.2006.047464.","journal-title":"J Med Genet"},{"issue":"10","key":"771_CR40","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.nmd.2004.05.002","volume":"14","author":"S Tuffery-Giraud","year":"2004","unstructured":"Tuffery-Giraud S, Saquet C, Chambert S, et al: The role of muscle biopsy in analysis of the dystrophin gene in Duchenne muscular dystrophy: experience of a national referral centre. Neuromuscul Disord. 2004, 14 (10): 650-8. 10.1016\/j.nmd.2004.05.002.","journal-title":"Neuromuscul Disord"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-12-37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2350-12-37\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-12-37","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-12-37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:07:33Z","timestamp":1630501653000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-12-37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,11]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["771"],"URL":"https:\/\/doi.org\/10.1186\/1471-2350-12-37","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,11]]},"assertion":[{"value":"2 November 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"37"}}